UPDATED Sep 13, 2025
Discover large cap Belgian Pharmaceuticals & Biotech companies that are on the BEL20. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ARGX | €644.40 | 0.7% | 32.0% | €39.4b | €712.24 | PE36.1x | E25.8% | n/a | ||
UCB | €207.40 | 0.2% | 27.3% | €39.4b | €226.11 | PE29.6x | E17.4% | 0.7% | ||
TUB | €169.20 | 1.4% | 28.2% | €7.5b | €186.50 | PE81.2x | n/a | 0.6% | ||
HYL | €6.34 | -0.9% | 33.5% | €177.5m | €13.00 | PS18.2x | E60.0% | n/a | ||
ALEMS | €4.65 | 0% | -32.6% | €19.7m | n/a | PE36x | n/a | n/a | ||
CYAD | €0.30 | -1.3% | 29.7% | €13.5m | n/a | PS72.4x | n/a | n/a | ||
BIOS | €0.0026 | 0% | -69.4% | €1.7m | n/a | PE-0.2x | n/a | n/a | ||
OXUR | €0.023 | 1.8% | -96.2% | €1.2m | n/a | PE9.7x | n/a | n/a |